{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:40:34Z","timestamp":1773283234290,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470282"],"award-info":[{"award-number":["81470282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500090"],"award-info":[{"award-number":["81500090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600090"],"award-info":[{"award-number":["81600090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870098"],"award-info":[{"award-number":["81870098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18ZR1407200"],"award-info":[{"award-number":["18ZR1407200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["20134Y117"],"award-info":[{"award-number":["20134Y117"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["20144Y0194"],"award-info":[{"award-number":["20144Y0194"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010108","name":"Zhongshan Hospital","doi-asserted-by":"publisher","award":["2015ZSYXGG09"],"award-info":[{"award-number":["2015ZSYXGG09"]}],"id":[{"id":"10.13039\/501100010108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00277-019-03716-9","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T08:35:28Z","timestamp":1559378128000},"page":"1845-1854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The abnormal function of CD39+ regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia"],"prefix":"10.1007","volume":"98","author":[{"given":"Yumeng","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luya","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxia","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9581-1134","authenticated-orcid":false,"given":"Yunfeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"issue":"11","key":"3716_CR1","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386\u20132393. \n                    https:\/\/doi.org\/10.1182\/blood-2008-07-162503","journal-title":"Blood"},{"key":"3716_CR2","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fimmu.2018.00880","volume":"9","author":"M Swinkels","year":"2018","unstructured":"Swinkels M, Rijkers M, Voorberg J, Vidarsson G, Leebeek FWG, Jansen AJG (2018) Emerging concepts in immune thrombocytopenia. Front Immunol 9:880. \n                    https:\/\/doi.org\/10.3389\/fimmu.2018.00880","journal-title":"Front Immunol"},{"issue":"3","key":"3716_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0037-1963(00)90102-1","volume":"37","author":"R McMillan","year":"2000","unstructured":"McMillan R (2000) Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol 37(3):239\u2013248","journal-title":"Semin Hematol"},{"issue":"4","key":"3716_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1034\/j.1600-0609.2003.00138.x","volume":"71","author":"H Ogawara","year":"2003","unstructured":"Ogawara H, Handa H, Morita K, Hayakawa M, Kojima J, Amagai H, Tsumita Y, Kaneko Y, Tsukamoto N, Nojima Y, Murakami H (2003) High Th1\/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol 71(4):283\u2013288","journal-title":"Eur J Haematol"},{"issue":"1","key":"3716_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12865-017-0210-3","volume":"18","author":"N Takahashi","year":"2017","unstructured":"Takahashi N, Saitoh T, Gotoh N, Nitta Y, Alkebsi L, Kasamatsu T, Minato Y, Yokohama A, Tsukamoto N, Handa H, Murakami H (2017) The cytokine polymorphisms affecting Th1\/Th2 increase the susceptibility to, and severity of, chronic ITP. BMC Immunol 18(1):26. \n                    https:\/\/doi.org\/10.1186\/s12865-017-0210-3","journal-title":"BMC Immunol"},{"issue":"6","key":"3716_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.humimm.2010.02.010","volume":"71","author":"D Gu","year":"2010","unstructured":"Gu D, Chen Z, Zhao H, Du W, Xue F, Ge J, Sui T, Wu H, Liu B, Lu S, Zhang L, Yang R (2010) Th1 (CXCL10) and Th2 (CCL2) chemokine expression in patients with immune thrombocytopenia. Hum Immunol 71(6):586\u2013591. \n                    https:\/\/doi.org\/10.1016\/j.humimm.2010.02.010","journal-title":"Hum Immunol"},{"issue":"4","key":"3716_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1600-0609.2007.00917.x","volume":"79","author":"Y Ling","year":"2007","unstructured":"Ling Y, Cao X, Yu Z, Ruan C (2007) Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur J Haematol 79(4):310\u2013316. \n                    https:\/\/doi.org\/10.1111\/j.1600-0609.2007.00917.x","journal-title":"Eur J Haematol"},{"issue":"2","key":"3716_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0609.2006.00780.x","volume":"78","author":"B Liu","year":"2007","unstructured":"Liu B, Zhao H, Poon MC, Han Z, Gu D, Xu M, Jia H, Yang R, Han ZC (2007) Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol 78(2):139\u2013143. \n                    https:\/\/doi.org\/10.1111\/j.1600-0609.2006.00780.x","journal-title":"Eur J Haematol"},{"issue":"22","key":"3716_CR9","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1182\/blood-2010-04-281717","volume":"116","author":"W Bao","year":"2010","unstructured":"Bao W, Bussel JB, Heck S, He W, Karpoff M, Boulad N, Yazdanbakhsh K (2010) Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood 116(22):4639\u20134645. \n                    https:\/\/doi.org\/10.1182\/blood-2010-04-281717","journal-title":"Blood"},{"issue":"4","key":"3716_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.exphem.2012.01.001","volume":"40","author":"T Nishimoto","year":"2012","unstructured":"Nishimoto T, Satoh T, Takeuchi T, Ikeda Y, Kuwana M (2012) Critical role of CD4(+)CD25(+) regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia. Exp Hematol 40(4):279\u2013289. \n                    https:\/\/doi.org\/10.1016\/j.exphem.2012.01.001","journal-title":"Exp Hematol"},{"issue":"4","key":"3716_CR11","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1182\/blood-2007-12-129262","volume":"112","author":"R Stasi","year":"2008","unstructured":"Stasi R, Cooper N, Del Poeta G, Stipa E, Laura Evangelista M, Abruzzese E, Amadori S (2008) Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood 112(4):1147\u20131150. \n                    https:\/\/doi.org\/10.1182\/blood-2007-12-129262","journal-title":"Blood"},{"issue":"10","key":"3716_CR12","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1182\/blood-2012-02-413526","volume":"120","author":"R Aslam","year":"2012","unstructured":"Aslam R, Hu Y, Gebremeskel S, Segel GB, Speck ER, Guo L, Kim M, Ni H, Freedman J, Semple JW (2012) Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia. Blood 120(10):2127\u20132132. \n                    https:\/\/doi.org\/10.1182\/blood-2012-02-413526","journal-title":"Blood"},{"key":"3716_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10245332.2018.1435021","volume":"23","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhang Q, Li Y, Tao L, Wu F, Shen Y, Tao Q, Xu X, Wu C, Ruan Y, Wang J, Wang J, Wang Y, Zhai Z (2018) Immune dysregulation in primary immune thrombocytopenia patients. Hematology 23:1\u20137. \n                    https:\/\/doi.org\/10.1080\/10245332.2018.1435021","journal-title":"Hematology"},{"issue":"1\u20132","key":"3716_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.imlet.2013.08.006","volume":"154","author":"J Li","year":"2013","unstructured":"Li J, Wang Z, Hu S, Zhao X, Cao L (2013) Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura. Immunol Lett 154(1\u20132):42\u201348. \n                    https:\/\/doi.org\/10.1016\/j.imlet.2013.08.006","journal-title":"Immunol Lett"},{"issue":"3","key":"3716_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12026-014-8620-2","volume":"61","author":"F Li","year":"2015","unstructured":"Li F, Ji L, Wang W, Hua F, Zhan Y, Zou S, Yuan L, Ke Y, Min Z, Song D, Sun L, Chen H, Cheng Y (2015) Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients. Immunol Res 61(3):269\u2013280. \n                    https:\/\/doi.org\/10.1007\/s12026-014-8620-2","journal-title":"Immunol Res"},{"issue":"Suppl 1","key":"3716_CR16","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1053\/j.seminhematol.2013.03.018","volume":"50","author":"T Nishimoto","year":"2013","unstructured":"Nishimoto T, Kuwana M (2013) CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia. Semin Hematol 50(Suppl 1):S43\u2013S49. \n                    https:\/\/doi.org\/10.1053\/j.seminhematol.2013.03.018","journal-title":"Semin Hematol"},{"issue":"12","key":"3716_CR17","doi-asserted-by":"publisher","first-page":"e50909","DOI":"10.1371\/journal.pone.0050909","volume":"7","author":"L Ji","year":"2012","unstructured":"Ji L, Zhan Y, Hua F, Li F, Zou S, Wang W, Song D, Min Z, Chen H, Cheng Y (2012) The ratio of Treg\/Th17 cells correlates with the disease activity of primary immune thrombocytopenia. PLoS One 7(12):e50909. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0050909","journal-title":"PLoS One"},{"issue":"6","key":"3716_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204(6):1257\u20131265. \n                    https:\/\/doi.org\/10.1084\/jem.20062512","journal-title":"J Exp Med"},{"issue":"11","key":"3716_CR19","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1111\/j.1600-6143.2010.03291.x","volume":"10","author":"KM Dwyer","year":"2010","unstructured":"Dwyer KM, Hanidziar D, Putheti P, Hill PA, Pommey S, McRae JL, Winterhalter A, Doherty G, Deaglio S, Koulmanda M, Gao W, Robson SC, Strom TB (2010) Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 10(11):2410\u20132420. \n                    https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03291.x","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"2","key":"3716_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1432-1033.2001.01896.x","volume":"268","author":"P Heine","year":"2001","unstructured":"Heine P, Braun N, Sevigny J, Robson SC, Servos J, Zimmermann H (2001) The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2. European J Biochem FEBS 268(2):364\u2013373","journal-title":"European J Biochem FEBS"},{"issue":"4","key":"3716_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nm0402-358","volume":"8","author":"N Mizumoto","year":"2002","unstructured":"Mizumoto N, Kumamoto T, Robson SC, Sevigny J, Matsue H, Enjyoji K, Takashima A (2002) CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8(4):358\u2013365. \n                    https:\/\/doi.org\/10.1038\/nm0402-358","journal-title":"Nat Med"},{"issue":"2","key":"3716_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","volume":"2","author":"SC Robson","year":"2006","unstructured":"Robson SC, Sevigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2(2):409\u2013430. \n                    https:\/\/doi.org\/10.1007\/s11302-006-9003-5","journal-title":"Purinergic Signal"},{"issue":"10","key":"3716_CR23","doi-asserted-by":"publisher","first-page":"6780","DOI":"10.4049\/jimmunol.177.10.6780","volume":"177","author":"JJ Kobie","year":"2006","unstructured":"Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR (2006) T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5\u2032-adenosine monophosphate to adenosine. J Immunol 177(10):6780\u20136786","journal-title":"J Immunol"},{"issue":"14","key":"3716_CR24","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/onc.2012.269","volume":"32","author":"J Bastid","year":"2013","unstructured":"Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A (2013) ENTPD1\/CD39 is a promising therapeutic target in oncology. Oncogene 32(14):1743\u20131751. \n                    https:\/\/doi.org\/10.1038\/onc.2012.269","journal-title":"Oncogene"},{"issue":"4","key":"3716_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s11302-016-9529-0","volume":"12","author":"M de Oliveira Bravo","year":"2016","unstructured":"de Oliveira Bravo M, Carvalho JL, Saldanha-Araujo F (2016) Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression. Purinergic Signal 12(4):595\u2013609. \n                    https:\/\/doi.org\/10.1007\/s11302-016-9529-0","journal-title":"Purinergic Signal"},{"issue":"7","key":"3716_CR26","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/sj.cdd.4402132","volume":"14","author":"BB Fredholm","year":"2007","unstructured":"Fredholm BB (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14(7):1315\u20131323. \n                    https:\/\/doi.org\/10.1038\/sj.cdd.4402132","journal-title":"Cell Death Differ"},{"issue":"4","key":"3716_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0006-2952(00)00570-0","volume":"61","author":"BB Fredholm","year":"2001","unstructured":"Fredholm BB, Irenius E, Kull B, Schulte G (2001) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61(4):443\u2013448","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"3716_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/biom5020775","volume":"5","author":"MS Alam","year":"2015","unstructured":"Alam MS, Costales MG, Cavanaugh C, Williams K (2015) Extracellular adenosine generation in the regulation of pro-inflammatory responses and pathogen colonization. Biomolecules 5(2):775\u2013792. \n                    https:\/\/doi.org\/10.3390\/biom5020775","journal-title":"Biomolecules"},{"issue":"10","key":"3716_CR29","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1074\/jbc.M109.047423","volume":"285","author":"M Mandapathil","year":"2010","unstructured":"Mandapathil M, Hilldorfer B, Szczepanski MJ, Czystowska M, Szajnik M, Ren J, Lang S, Jackson EK, Gorelik E, Whiteside TL (2010) Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J Biol Chem 285(10):7176\u20137186. \n                    https:\/\/doi.org\/10.1074\/jbc.M109.047423","journal-title":"J Biol Chem"},{"key":"3716_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2011.09.013","volume":"240-241","author":"E Peelen","year":"2011","unstructured":"Peelen E, Damoiseaux J, Smolders J, Knippenberg S, Menheere P, Tervaert JW, Hupperts R, Thewissen M (2011) Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse. J Neuroimmunol 240-241:97\u2013103. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2011.09.013","journal-title":"J Neuroimmunol"},{"issue":"12","key":"3716_CR31","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1177\/1352458514567215","volume":"21","author":"NG Muls","year":"2015","unstructured":"Muls NG, Dang HA, Sindic CJ, van Pesch V (2015) Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse. Mult Scler 21(12):1533\u20131545. \n                    https:\/\/doi.org\/10.1177\/1352458514567215","journal-title":"Mult Scler"},{"issue":"11","key":"3716_CR32","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","volume":"183","author":"JM Fletcher","year":"2009","unstructured":"Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KH (2009) CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 183(11):7602\u20137610. \n                    https:\/\/doi.org\/10.4049\/jimmunol.0901881","journal-title":"J Immunol"},{"issue":"39","key":"3716_CR33","doi-asserted-by":"publisher","first-page":"16788","DOI":"10.1073\/pnas.0902869106","volume":"106","author":"DJ Friedman","year":"2009","unstructured":"Friedman DJ, Kunzli BM, Yi AR, Sevigny J, Berberat PO, Enjyoji K, Csizmadia E, Friess H, Robson SC (2009) From the cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A 106(39):16788\u201316793. \n                    https:\/\/doi.org\/10.1073\/pnas.0902869106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3716_CR34","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/hep.26583","volume":"59","author":"CR Grant","year":"2014","unstructured":"Grant CR, Liberal R, Holder BS, Cardone J, Ma Y, Robson SC, Mieli-Vergani G, Vergani D, Longhi MS (2014) Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology 59(3):1007\u20131015. \n                    https:\/\/doi.org\/10.1002\/hep.26583","journal-title":"Hepatology"},{"issue":"1","key":"3716_CR35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cellimm.2011.06.010","volume":"271","author":"MJ Loza","year":"2011","unstructured":"Loza MJ, Anderson AS, O'Rourke KS, Wood J, Khan IU (2011) T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus. Cell Immunol 271(1):110\u2013117. \n                    https:\/\/doi.org\/10.1016\/j.cellimm.2011.06.010","journal-title":"Cell Immunol"},{"key":"3716_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaut.2018.01.004","volume":"90","author":"RS Peres","year":"2018","unstructured":"Peres RS, Donate PB, Talbot J, Cecilio NT, Lobo PR, Machado CC, Lima KWA, Oliveira RD, Carregaro V, Nakaya HI, Cunha TM, Alves-Filho JC, Liew FY, Louzada-Junior P, Cunha FQ (2018) TGF-beta signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis. J Autoimmun 90:49\u201358. \n                    https:\/\/doi.org\/10.1016\/j.jaut.2018.01.004","journal-title":"J Autoimmun"},{"issue":"12","key":"3716_CR37","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1097\/MIB.0000000000000566","volume":"21","author":"DJ Gibson","year":"2015","unstructured":"Gibson DJ, Elliott L, McDermott E, Tosetto M, Keegan D, Byrne K, Martin ST, Rispens T, Cullen G, Mulcahy HE, Cheifetz AS, Moss AC, Robson SC, Doherty GA, Ryan EJ (2015) Heightened expression of CD39 by regulatory T lymphocytes is associated with therapeutic remission in inflammatory bowel disease. Inflamm Bowel Dis 21(12):2806\u20132814. \n                    https:\/\/doi.org\/10.1097\/MIB.0000000000000566","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"3716_CR38","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/eji.201142088","volume":"42","author":"N Li","year":"2012","unstructured":"Li N, Mu L, Wang J, Zhang J, Xie X, Kong Q, Tang W, Yao X, Liu Y, Wang L, Wang G, Wang D, Jin L, Sun B, Li H (2012) Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity. Eur J Immunol 42(5):1140\u20131151. \n                    https:\/\/doi.org\/10.1002\/eji.201142088","journal-title":"Eur J Immunol"},{"issue":"8","key":"3716_CR39","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.imbio.2015.02.007","volume":"220","author":"JM Guzman-Flores","year":"2015","unstructured":"Guzman-Flores JM, Cortez-Espinosa N, Cortes-Garcia JD, Vargas-Morales JM, Catano-Canizalez YG, Rodriguez-Rivera JG, Portales-Perez DP (2015) Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus. Immunobiology 220(8):976\u2013984. \n                    https:\/\/doi.org\/10.1016\/j.imbio.2015.02.007","journal-title":"Immunobiology"},{"issue":"2","key":"3716_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115(2):168\u2013186. \n                    https:\/\/doi.org\/10.1182\/blood-2009-06-225565","journal-title":"Blood"},{"issue":"16","key":"3716_CR41","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA, American Society of H (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117(16):4190\u20134207. \n                    https:\/\/doi.org\/10.1182\/blood-2010-08-302984","journal-title":"Blood"},{"issue":"1","key":"3716_CR42","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1182\/blood-2008-06-165746","volume":"113","author":"HK Eltzschig","year":"2009","unstructured":"Eltzschig HK, Kohler D, Eckle T, Kong T, Robson SC, Colgan SP (2009) Central role of Sp1-regulated CD39 in hypoxia\/ischemia protection. Blood 113(1):224\u2013232. \n                    https:\/\/doi.org\/10.1182\/blood-2008-06-165746","journal-title":"Blood"},{"key":"3716_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/B978-0-12-385526-8.00010-2","volume":"61","author":"S Deaglio","year":"2011","unstructured":"Deaglio S, Robson SC (2011) Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol 61:301\u2013332. \n                    https:\/\/doi.org\/10.1016\/B978-0-12-385526-8.00010-2","journal-title":"Adv Pharmacol"},{"issue":"5","key":"3716_CR44","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.4049\/jimmunol.177.5.2765","volume":"177","author":"M Naganuma","year":"2006","unstructured":"Naganuma M, Wiznerowicz EB, Lappas CM, Linden J, Worthington MT, Ernst PB (2006) Cutting edge: critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunol 177(5):2765\u20132769","journal-title":"J Immunol"},{"issue":"7","key":"3716_CR45","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.4049\/jimmunol.178.7.4240","volume":"178","author":"CP Sevigny","year":"2007","unstructured":"Sevigny CP, Li L, Awad AS, Huang L, McDuffie M, Linden J, Lobo PI, Okusa MD (2007) Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol 178(7):4240\u20134249","journal-title":"J Immunol"},{"issue":"2","key":"3716_CR46","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4049\/jimmunol.174.2.1073","volume":"174","author":"CM Lappas","year":"2005","unstructured":"Lappas CM, Rieger JM, Linden J (2005) A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol 174(2):1073\u20131080","journal-title":"J Immunol"},{"issue":"10","key":"3716_CR47","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1096\/fj.08-107458","volume":"22","author":"B Csoka","year":"2008","unstructured":"Csoka B, Himer L, Selmeczy Z, Vizi ES, Pacher P, Ledent C, Deitch EA, Spolarics Z, Nemeth ZH, Hasko G (2008) Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J : official publication of the Federation of American Societies for Experimental Biology 22(10):3491\u20133499. \n                    https:\/\/doi.org\/10.1096\/fj.08-107458","journal-title":"FASEB J : official publication of the Federation of American Societies for Experimental Biology"},{"issue":"4","key":"3716_CR48","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Hopner S, Centonze D, Bernardi G, Dell\u2019Acqua ML, Rossini PM, Battistini L, Rotzschke O, Falk K (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110(4):1225\u20131232. \n                    https:\/\/doi.org\/10.1182\/blood-2006-12-064527","journal-title":"Blood"},{"issue":"1","key":"3716_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/blood-2007-03-081646","volume":"111","author":"PE Zarek","year":"2008","unstructured":"Zarek PE, Huang CT, Lutz ER, Kowalski J, Horton MR, Linden J, Drake CG, Powell JD (2008) A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111(1):251\u2013259. \n                    https:\/\/doi.org\/10.1182\/blood-2007-03-081646","journal-title":"Blood"},{"issue":"1","key":"3716_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2005.05.032","volume":"129","author":"M Odashima","year":"2005","unstructured":"Odashima M, Bamias G, Rivera-Nieves J, Linden J, Nast CC, Moskaluk CA, Marini M, Sugawara K, Kozaiwa K, Otaka M, Watanabe S, Cominelli F (2005) Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 129(1):26\u201333","journal-title":"Gastroenterology"},{"issue":"1","key":"3716_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/iid3.187","volume":"6","author":"Y Liu","year":"2018","unstructured":"Liu Y, Alahiri M, Ulloa B, Xie B, Sadiq SA (2018) Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway. Immun Inflammation Dis 6(1):72\u201380. \n                    https:\/\/doi.org\/10.1002\/iid3.187","journal-title":"Immun Inflammation Dis"},{"key":"3716_CR52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neuroscience.2016.05.028","volume":"330","author":"Y Liu","year":"2016","unstructured":"Liu Y, Zou H, Zhao P, Sun B, Wang J, Kong Q, Mu L, Zhao S, Wang G, Wang D, Zhang Y, Zhao J, Yin P, Liu L, Zhao X, Li H (2016) Activation of the adenosine A2A receptor attenuates experimental autoimmune encephalomyelitis and is associated with increased intracellular calcium levels. Neuroscience 330:150\u2013161. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2016.05.028","journal-title":"Neuroscience"},{"issue":"1","key":"3716_CR53","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4049\/jimmunol.1201325","volume":"190","author":"KL Han","year":"2013","unstructured":"Han KL, Thomas SV, Koontz SM, Changpriroa CM, Ha SK, Malech HL, Kang EM (2013) Adenosine A(2) A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease. J Immunol 190(1):458\u2013468. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1201325","journal-title":"J Immunol"},{"issue":"2","key":"3716_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1189\/jlb.0609388","volume":"87","author":"CM Lappas","year":"2010","unstructured":"Lappas CM, Liu PC, Linden J, Kang EM, Malech HL (2010) Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation. J Leukoc Biol 87(2):345\u2013354. \n                    https:\/\/doi.org\/10.1189\/jlb.0609388","journal-title":"J Leukoc Biol"},{"issue":"7","key":"3716_CR55","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.neo.2017.02.004","volume":"19","author":"M Mediavilla-Varela","year":"2017","unstructured":"Mediavilla-Varela M, Castro J, Chiappori A, Noyes D, Hernandez DC, Allard B, Stagg J, Antonia SJ (2017) A novel antagonist of the immune checkpoint protein adenosine A2a receptor restores tumor-infiltrating lymphocyte activity in the context of the tumor microenvironment. Neoplasia 19(7):530\u2013536. \n                    https:\/\/doi.org\/10.1016\/j.neo.2017.02.004","journal-title":"Neoplasia"},{"key":"3716_CR56","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fphar.2017.00888","volume":"8","author":"S Gessi","year":"2017","unstructured":"Gessi S, Bencivenni S, Battistello E, Vincenzi F, Colotta V, Catarzi D, Varano F, Merighi S, Borea PA, Varani K (2017) Inhibition of A2A adenosine receptor signaling in cancer cells proliferation by the novel antagonist TP455. Front Pharmacol 8:888. \n                    https:\/\/doi.org\/10.3389\/fphar.2017.00888","journal-title":"Front Pharmacol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03716-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03716-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03716-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T23:32:47Z","timestamp":1590881567000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03716-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3716"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03716-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]},"assertion":[{"value":"3 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by local Medical Ethics Committees of Zhongshan Hospital, Fudan University. Written informed consent was obtained from each patient enrolled in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Data sharing: no additional data available","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing statement"}}]}}